• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Outlook Therapeutics, Inc. - Common Stock (NQ: OTLK )

    1.470 UNCHANGED
    Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 1.380 (5)
    Ask (Size) 1.470 (11)
    Prev. Close 1.470
    Today's Range 1.470 - 1.470
    52wk Range 0.8700 - 12.85
    Shares Outstanding 23,655,636
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    This Kohl's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga

    Performance

    YTD
    -81.30%
    -81.30%
    1 Month
    -70.18%
    -70.18%
    3 Month
    -73.37%
    -73.37%
    6 Month
    -79.44%
    -79.44%
    1 Year
    -83.52%
    -83.52%

    More News

    Read More
    Nasdaq Down Over 100 Points; HP Shares Plunge
    Via Benzinga
    Dow Falls Over 100 Points; US Crude Oil Stocks Decline
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    US Stocks Mixed; Economy Grows By 2.8% In Q3
    Via Benzinga
    Topics Economy
    Exposures Economy
    Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Lower On Wednesday?
    Via Benzinga
    OUTLOOK ALERT: Bragar Eagel & Squire, P.C. is Investigating Outlook Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    OTLK Stock Earnings: Outlook Therapeutics Beats EPS for Q3 2024
    Via InvestorPlace
    3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices
    Via MarketBeat
    3 Undervalued Gems Set to Soar 1,000% by 2026
    Via InvestorPlace
    MarketBeat Week in Review – 6/17 - 6/21
    Via MarketBeat
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside
    Via MarketBeat
    OTLK Stock Earnings: Outlook Therapeutics Misses EPS for Q2 2024
    Via InvestorPlace
    Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
    Via InvestorPlace
    Insiders Buying Outlook Therapeutics And 2 Other Stocks
    Via Benzinga
    Gold Moves Lower; Lululemon Shares Plummet
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Dow Dips 200 Points; Nike Shares Fall After Q3 Results
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Higher On Friday?
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Over $1.7M Bet On Globalstar? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    7 of the Best Speculative Stocks You Can Snag for Less Than $1
    Via InvestorPlace
    7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
    Via InvestorPlace
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.